Economy

The S&P 500 hit a new intraday record high on Dec 24, 2025, as investors grow more confident about potential Federal Reserve interest rate cuts. We analyze the market optimism and potential risks.

Japanese trading giant Itochu is partnering with Taiwanese cross-border e-commerce site Bibian to boost overseas sales for lesser-known anime, signaling a new strategy for monetizing long-tail IP.

Subaru is mitigating the impact of U.S. tariffs through lower levies and price hikes, allowing it to maintain its long-term sales goal of 1.2 million vehicles.

USDC issuer Circle has confirmed that a press release announcing a 'CircleMetals' gold and silver token platform is fake. The announcement, made on Christmas Eve, is a likely phishing scam.

After a disappointing 2025 with only 6% growth, Amazon stock is targeting a 2026 rebound. Key drivers include AWS's reaccelerated growth and a burgeoning ad business, but the biggest challenge lies in securing power for its AI infrastructure expansion.

Japan's government is finalizing a record $785 billion budget for fiscal 2026, assuming a 3% interest rate for debt servicing. The move signals a major shift away from the era of ultra-low rates.

XRP's price has fallen 1.7% despite the launch of 'earnXRP', a new DeFi yield product. Analytics firm Santiment notes that current negative social sentiment could be a contrarian signal for a rebound.

Starting January 1, 2025, the EU's DAC8 directive mandates crypto exchanges to report user data to tax authorities. Non-compliance could lead to penalties and even asset seizure for users.

A deep dive into the Aave community's split over brand control between its DAO and Aave Labs, a conflict that puts the future of DeFi governance for the $33B protocol into question.

Aptos (APT) has slipped 1% to $1.56 amid broader market weakness and thin holiday trading. We analyze the key technical battle between $1.63 resistance and $1.56 support.

Nike's stock price saw a boost after a filing revealed Apple CEO Tim Cook purchased $3 million worth of shares. We analyze what this high-profile investment signals for the iconic brand.

Discover how the approval of new weight-loss drugs is forcing food giants like Nestlé to overhaul their products. An analysis of the 'Ozempic effect' on consumer habits and the investment landscape.